532 related articles for article (PubMed ID: 32560122)
1. How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.
Lontay B; Kiss A; Virág L; Tar K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560122
[TBL] [Abstract][Full Text] [Related]
2. Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity.
Arbez N; Ratovitski T; Roby E; Chighladze E; Stewart JC; Ren M; Wang X; Lavery DJ; Ross CA
J Biol Chem; 2017 Nov; 292(47):19238-19249. PubMed ID: 28972180
[TBL] [Abstract][Full Text] [Related]
3. Proteostasis of Huntingtin in Health and Disease.
Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
[TBL] [Abstract][Full Text] [Related]
4. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
5. Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats.
Ratovitski T; O'Meally RN; Jiang M; Chaerkady R; Chighladze E; Stewart JC; Wang X; Arbez N; Roby E; Alexandris A; Duan W; Vijayvargia R; Seong IS; Lavery DJ; Cole RN; Ross CA
J Proteome Res; 2017 Aug; 16(8):2692-2708. PubMed ID: 28653853
[TBL] [Abstract][Full Text] [Related]
6. A human huntingtin SNP alters post-translational modification and pathogenic proteolysis of the protein causing Huntington disease.
Martin DDO; Kay C; Collins JA; Nguyen YT; Slama RA; Hayden MR
Sci Rep; 2018 May; 8(1):8096. PubMed ID: 29802276
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance.
Martin DDO; Schmidt ME; Nguyen YT; Lazic N; Hayden MR
FASEB J; 2019 Mar; 33(3):3190-3197. PubMed ID: 30423259
[TBL] [Abstract][Full Text] [Related]
8. The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.
Wanker EE; Ast A; Schindler F; Trepte P; Schnoegl S
J Neurochem; 2019 Nov; 151(4):507-519. PubMed ID: 31418858
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
Akbergenova Y; Littleton JT
J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
[TBL] [Abstract][Full Text] [Related]
10. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
Chen M; Wolynes PG
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
[TBL] [Abstract][Full Text] [Related]
11. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity.
Pan Y; Zhu Y; Yang W; Tycksen E; Liu S; Palucki J; Zhu L; Sasaki Y; Sharma MK; Kim AH; Zhang B; Yano H
J Biol Chem; 2018 Jul; 293(30):11850-11866. PubMed ID: 29891550
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of Site-Specific Ubiquitination on Chaperones in Response to Mutant Huntingtin.
Panda P; Sarohi V; Basak T; Kasturi P
Cell Mol Neurobiol; 2023 Dec; 44(1):3. PubMed ID: 38102300
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutant and total huntingtin expression in Huntington's disease murine models.
Fodale V; Pintauro R; Daldin M; Altobelli R; Spiezia MC; Bisbocci M; Macdonald D; Bresciani A
Sci Rep; 2020 Dec; 10(1):22137. PubMed ID: 33335120
[TBL] [Abstract][Full Text] [Related]
14. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
Aladdin A; Király R; Boto P; Regdon Z; Tar K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
[TBL] [Abstract][Full Text] [Related]
15. Targeting the proteostasis network in Huntington's disease.
Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathogenesis in Huntington's Disease.
Illarioshkin SN; Klyushnikov SA; Vigont VA; Seliverstov YA; Kaznacheyeva EV
Biochemistry (Mosc); 2018 Sep; 83(9):1030-1039. PubMed ID: 30472941
[TBL] [Abstract][Full Text] [Related]
17. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
18. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
Podvin S; Reardon HT; Yin K; Mosier C; Hook V
J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation.
Cariulo C; Azzollini L; Verani M; Martufi P; Boggio R; Chiki A; Deguire SM; Cherubini M; Gines S; Marsh JL; Conforti P; Cattaneo E; Santimone I; Squitieri F; Lashuel HA; Petricca L; Caricasole A
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):E10809-E10818. PubMed ID: 29162692
[TBL] [Abstract][Full Text] [Related]
20. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
